Shimada Muneaki 島田宗昭

… Alternative Names

SHIMADA Muneaki 島田宗昭

Less

Researcher Number	40362892
Other IDs
Affiliation (Current)	2025: 東北大学, 未来型医療創成センター, 教授
Affiliation (based on the past Project Information) *help	2022 – 2024: 東北大学, 未来型医療創成センター, 教授 2018 – 2021: 東北大学, 医学系研究科, 准教授 2017: 東北大学, 大学病院, 准教授 2014 – 2015: 鳥取大学, 医学部, 講師 2012 – 2013: 鳥取大学, 医学部, 助教 2007: Maori University, Faculty of Medicine, Assistant Professor 2006: 鳥取大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology Except Principal Investigator Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology / Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator メタボローム解析 / 難治性がん / 鑑別診断 / 難治性 / 化学療法抵抗性 / 粘液性癌 / 卵巣癌 / 難治性癌 / プロテオーム解析 / オミックス解析 … More / 多層的オミックス解析 / 婦人科難治性希少がん / 卵巣粘液性癌 / 放射線感受性 / 化学療法感受性 / 非扁平上皮癌 / 個別化医療 / 集学的治療 / 化学療法 / 組織亜型 / 子宮頸癌 … More Except Principal Investigator 卵巣癌 / メタボローム / 薬剤耐性 / 白金製剤 / 明細胞癌 / マルチオミックス / プロテオーム / メタボローム解析 / 全ゲノム解析 / 全エクソーム解析 / 卵巣明細胞癌 / 前向きコホート研究 / リスク低減卵管卵巣摘出術 / BRCA1，BRCA2 / 遺伝性腫瘍 / 遺伝性乳癌卵巣癌症候群 / 白金抵抗性 / 卵巣がん / セラミド / クロマチンリモデリング / 循環腫瘍DNA / がんゲノム解析 / 婦人科がん / メタボロミクス / オミックス / バイオマーカー / プラチナ耐性 / オルガノイドモデル / プラチナ感受性 / オルガノイド / CHD4 / 治療抵抗性 / Chemoresponse / Gene therapy / Carcinoma / 薬剤反応性 / 遺伝子 / 癌 / mTOR阻害剤 / PI3K阻害剤 / PIK3CA / PI3K / 明細胞腺癌 / FGFR2 / 卵巣明細胞腺癌 Less

Multicenter study to stratify ovarian cancer risk factors in women with BRCA pathogenic variants carriers.
- Principal Investigator
  
  平沢晃
- Project Period (FY)
  2024 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Okayama University
A multi-omics investigation of novel therapeutic strategies for clear cell carcinoma of the ovary focusing on cancer metabolism
- Principal Investigator
  
  重田昌吾
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Tohoku University
Development of a New Treatment Strategy for Refractory Ovarian Mucinous CarcinomaPrincipal Investigator
- Principal Investigator
  
  SHIMADA Muneaki
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Tohoku University
Elucidation of the mechanism of drug resistance in ovarian cancer with poor prognosis and development of new therapeutic targets
- Principal Investigator
  
  TOKUNAGA Hideki
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Tohoku University
An investigation of novel therapeutic strategies for platinum-resistant ovarian cancer using cancer organoid originated from disseminating ovarian carcinoma
- Principal Investigator
  
  TSUJI Keita
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Tohoku University
Comprehensive genomic and transcriptome analyses to clarify molecular mechanisms contributing to chemoresistance in gynecologic cancer
- Principal Investigator
  
  YAEGASHI Nobuo
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Tohoku University
An attempt to establish a new treatment for non-squamous cell carcinoma of the uterine cervixPrincipal Investigator
- Principal Investigator
  
  SHIMADA Muneaki
- Project Period (FY)
  2017 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tohoku University
Development of combination therapy using PI3K inhibitor and its predictive biomarker in clear cell carcinoma of the ovary
- Principal Investigator
  
  Oishi Tetsuro
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University
Adenovirus type 5 EIA gene therapy for ovarian carcinoma
- Principal Investigator
  
  ITAMOCHI Hiroaki
- Project Period (FY)
  2005 – 2007
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Tottori University

All 2023 2022 2021 2020 2019 2018 2017 2015 2014 2013 2005 Other

All Journal Article Presentation Other

[Journal Article] Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas2023
- Author(s)
  Matsuo Koji、Matsuzaki Shinya、Maeda Michihide、Rau Alesandra R.、Yoshihara Kosuke、Tamura Ryo、Shimada Muneaki、Machida Hiroko、Mikami Mikio、Klar Maximilian、Roman Lynda D.、Wright Jason D.、Sood Anil K.、Gershenson David M.
- Journal Title
  
  JAMA Network Open
  
  Volume: 6 Issue: 6 Pages: 2318602-2318602
- DOI
  10.1001/jamanetworkopen.2023.18602
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K09635, KAKENHI-PROJECT-23K08854, KAKENHI-PROJECT-21K09486, KAKENHI-PROJECT-20H03828
[Journal Article] Identification of predictive biomarkers for diagnosis and radiation sensitivity of uterine cervical cancer using wide‐targeted metabolomics2023
- Author(s)
  Hishinuma Eiji、Shimada Muneaki、Matsukawa Naomi、Li Bin、Motoike Ikuko N.、Hagihara Tatsuya、Shigeta Shogo、Tokunaga Hideki、Saigusa Daisuke、Kinoshita Kengo、Koshiba Seizo、Yaegashi Nobuo
- Journal Title
  
  Journal of Obstetrics and Gynaecology Research
  
  Volume: 49 Issue: 8 Pages: 2109-2117
- DOI
  10.1111/jog.15709
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09486, KAKENHI-PROJECT-21K09531, KAKENHI-PROJECT-23K24478, KAKENHI-PROJECT-23K27316
[Journal Article] Homologous Recombination Inquiry Through Ovarian Malignancy Investigations: JGOG3025 study.2023
- Author(s)
  Yoshihara K, Baba T, Tokunaga H, Nishino K, Sekine M, Takamatsu S, Matsumura N, Yoshida H, Kajiyama H, Shimada M, Kagimura T, Oda K, Sasajima Y, Yaegashi N, Okamoto A, Sugiyama T, Enomoto T
- Journal Title
  
  Cancer Sci
  
  Volume: Online ahead of print Issue: 6 Pages: 2515-2523
- DOI
  10.1111/cas.15747
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-21K09531, KAKENHI-PROJECT-21H03074, KAKENHI-PROJECT-23K27741
[Journal Article] Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling2023
- Author(s)
  Hishinuma Eiji、Shimada Muneaki、Matsukawa Naomi、Shima Yoshiko、Li Bin、Motoike Ikuko N.、Shibuya Yusuke、Hagihara Tatsuya、Shigeta Shogo、Tokunaga Hideki、Saigusa Daisuke、Kinoshita Kengo、Koshiba Seizo、Yaegashi Nobuo
- Journal Title
  
  Cancer & Metabolism
  
  Volume: 11 Issue: 1
- DOI
  10.1186/s40170-023-00317-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09486, KAKENHI-PROJECT-21K09531, KAKENHI-PROJECT-23K24478, KAKENHI-PROJECT-23K27316
[Journal Article] An Attempt to Develop a New Treatment Strategy for Rare Refractory Gynecological Malignancies: The Japanese Gynecologic Oncology Group2023
- Author(s)
  Shigeta S, Shimada M, Suzuki S, Kajiyama H, Oda K, Takehara K, Mandai M, Aoki D, Enomoto T, Okamoto A.
- Journal Title
  
  JMA Journal
  
  Volume: 6 Issue: 4 Pages: 527-531
- DOI
  10.31662/jmaj.2023-0024
- ISSN
  2433-328X, 2433-3298
- Year and Date
  2023-10-16
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09486, KAKENHI-PROJECT-21H03074, KAKENHI-PROJECT-23K21473
[Journal Article] Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)2022
- Author(s)
  Takatori E, Nagasawa T, Kagabu M, Baba T, Shigeto T, Matsumura Y, Shimizu D, Terada Y, Seino M, Ohta T, Nagase S, Shigeta S, Tokunaga H, Shimada M, Kaiho-Sakuma M, Furukawa S, Soeda S, Watanabe T, Takahashi F, Yokoyama Y.
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 27 Issue: 12 Pages: 1874-1880
- DOI
  10.1007/s10147-022-02246-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09531, KAKENHI-PROJECT-21K09548
[Journal Article] A Retrospective Analysis of Clinical Biomarkers for Olaparib Maintenance Therapy in Patients with Recurrent Ovarian Cancer2022
- Author(s)
  Endo Shun、Shigeta Shogo、Tokunaga Hideki、Shimizu Takanori、Hasegawa-Minato Junko、Hashimoto Chiaki、Ishibashi Masumi、Nagai Tomoyuki、Shiga Naomi、Shimada Muneaki、Yaegashi Nobuo
- Journal Title
  
  Tohoku J. Exp. Med.
  
  Volume: 258 Issue: 1 Pages: 1-9
- DOI
  10.1620/tjem.2022.J050
- ISSN
  0040-8727, 1349-3329
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K09531
[Journal Article] Rethinking the significance of surgery for uterine cervical cancer.2022
- Author(s)
  Shimada M, Tsuji K, Shigeta S, Nagai T, Watanabe Z, Tokunaga H, Kigawa J, Yaegashi N.
- Journal Title
  
  J Obstet Gynaecol Res.
  
  Volume: 48(3) Issue: 3 Pages: 576-586
- DOI
  10.1111/jog.15112
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03795
[Journal Article] MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 Expression2022
- Author(s)
  Shigeta S, Watanabe Y, Suzuki F, Nagase S, Shibuya Y, Ishibashi M, Nagai T, Shiga N, Toyoshima M, Tokunaga H, Shimada M, Yaegashi N.
- Journal Title
  
  Tohoku J. Exp. Med.
  
  Volume: 256 Issue: 3 Pages: 249-258
- DOI
  10.1620/tjem.256.249
- ISSN
  0040-8727, 1349-3329
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03795
[Journal Article] Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gynecologic Oncology Group2022
- Author(s)
  Shigeta Shogo、Shimada Muneaki、Tsuji Keita、Nagai Tomoyuki、Tanase Yasuhito、Matsuo Koji、Kamiura Shoji、Iwata Takashi、Yokota Harushige、Mikami Mikio
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 27 Issue: 9 Pages: 1507-1515
- DOI
  10.1007/s10147-022-02198-6
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-22H04923
[Journal Article] Prognostic factors of 2018 FIGO stage IB-IIA cervical cancer with absence of high/ intermediate surgical-pathological risk factors2022
- Author(s)
  Shibuya Yusuke、Shimada Muneaki、Tsuji Keita、Shigeta Shogo、Tanase Yasuhito、Matsuo Koji、Yamaguchi Satoshi、Kanao Hiroyuki、Saito Toshiaki、Mikami Mikio
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 52 Pages: 1289-1296
- DOI
  10.1093/jjco/hyac125
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-22H04923
[Journal Article] Liquid biopsy with droplet digital PCR targeted to specific mutations in plasma cell-free tumor DNA can detect ovarian cancer recurrence earlier than CA125.2021
- Author(s)
  Minato T, Ito S, Li B, Fujimori H, Mochizuki M, Yamaguchi K, Tamai K, Shimada M, Tokunaga H, Shigeta S, Sato I, Shima H, Yamada H, Yaegashi N, Yasuda J.
- Journal Title
  
  Gynecol Oncol Rep.
  
  Volume: 38 Pages: 100847-100847
- DOI
  10.1016/j.gore.2021.100847
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-21K07137
[Journal Article] Clinico-pathological characteristics of patients with stage IB1-IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan.2021
- Author(s)
  Tsuji K, Shimada M, Takahashi F, Tokunaga H, Deura I, Yamaguchi S, Nakanishi T, Matsuo K, Yaegashi N, Mikami M.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 26(8) Issue: 8 Pages: 1541-1552
- DOI
  10.1007/s10147-021-01938-4
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-20H03828, KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-16H06277
[Journal Article] Prospective evaluation of sentinel node navigation surgery in Japanese patients with low-risk endometrial cancer-safety and occurrence of lymphedema.2021
- Author(s)
  Niikura H, Toki A, Nagai T, Okamoto S, Shigeta S, Tokunaga H, Shimada M, Watanabe M, Yaegashi N.
- Journal Title
  
  Jpn J Clin Oncol
  
  Volume: 51(4) Issue: 4 Pages: 584-589
- DOI
  10.1093/jjco/hyaa252
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03795
[Journal Article] Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2)2021
- Author(s)
  Tokunaga Hideki、Iida Keita、Hozawa Atsushi、Ogishima Soichi、Watanabe Yoh、Shigeta Shogo、Shimada Muneaki、Yamaguchi-Kabata Yumi、Tadaka Shu、Katsuoka Fumiki、Ito Shin、Kumada Kazuki、Hamanaka Yohei、Fuse Nobuo、Kinoshita Kengo、Yamamoto Masayuki、Yaegashi Nobuo、Yasuda Jun
- Journal Title
  
  PLOS ONE
  
  Volume: 16 Issue: 1 Pages: e0236907-e0236907
- DOI
  10.1371/journal.pone.0236907
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K11545, KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-17K07193, KAKENHI-PROJECT-21K07111
[Journal Article] Establishment of a Diagnostic Method for Pelvic Sentinel Lymph Node Metastasis by Contrast-Enhanced Ultrasound in Uterine Cancer.2021
- Author(s)
  Toki A, Niikura H, Mori N, Shigeta S, Nagai T, Tokunaga H, Shimada M, Yaegashi N.
- Journal Title
  
  Ultrasound Med Biol.
  
  Volume: 47(8) Issue: 8 Pages: 2107-2116
- DOI
  10.1016/j.ultrasmedbio.2021.03.040
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03795
[Journal Article] A Single Arm Prospective Pilot Study Examining the Efficacy and Safety of Bevacizumab Single Maintenance Therapy Following Platinum-Based Chemotherapy in Patients with Advanced or Recurrent Cervical Cancer.2021
- Author(s)
  Toyoshima M, Shimada M, Sasaki S, Ishibashi M, Shigeta S, Tsuji K, Nagai T, Tokunaga H, Niikura H, Yaegashi N.
- Journal Title
  
  Tohoku J Exp Med.
  
  Volume: 254(3) Issue: 3 Pages: 145-153
- DOI
  10.1620/tjem.254.145
- NAID
  130008061848
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-17K11265
[Journal Article] CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.2021
- Author(s)
  Oyama Y, Shigeta S, Tokunaga H, Tsuji K, Ishibashi M, Shibuya Y, Shimada M, Yasuda J, Yaegashi N.
- Journal Title
  
  PLoS One.
  
  Volume: 16(6) Issue: 6 Pages: 0251079-0251079
- DOI
  10.1371/journal.pone.0251079
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-19K09747, KAKENHI-PROJECT-21K09531, KAKENHI-PROJECT-20K18211
[Journal Article] Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine.2021
- Author(s)
  Shimada M, Sato S, Shoji T, Nagao S, Tokunaga H, Sueoka K, Takehara K, Nakamura K, Yamaguchi S, Kigawa J.
- Journal Title
  
  Int J Clin Oncol
  
  Volume: 26 Issue: 7 Pages: 1314-1321
- DOI
  10.1007/s10147-021-01903-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K11265
[Journal Article] The Impact of Histological Subtype on Survival Outcome of Patients with Stage IIB-IVA Cervical Cancer Who Received Definitive Radiotherapy2021
- Author(s)
  Miyahara S, Tsuji K, Shimada M, Shibuya Y, Shigeta S, Nagai T, Umezawa R, Tokunaga H, Jingu K, Yaegashi N.
- Journal Title
  
  Tohoku J. Exp. Med.
  
  Volume: 255 Issue: 4 Pages: 303-313
- DOI
  10.1620/tjem.255.303
- NAID
  130008129404
- ISSN
  0040-8727, 1349-3329
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03795, KAKENHI-PROJECT-17K11265
[Journal Article] Impact of Histopathological Risk Factors on the Treatment of Stage IB-IIB Uterine Cervical Cancer2020
- Author(s)
  Shimada Muneaki、Tokunaga Hideki、Kigawa Junzo、Yaegashi Nobuo
- Journal Title
  
  The Tohoku Journal of Experimental Medicine
  
  Volume: 252 Issue: 4 Pages: 339-351
- DOI
  10.1620/tjem.252.339
- NAID
  130007953560
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K11265
[Journal Article] Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence.2020
- Author(s)
  Matsuzaki S, Klar M, Mikami M, Shimada M, Grubbs BH, Fujiwara K, Roman LD, Matsuo K
- Journal Title
  
  Curr Oncol Rep
  
  Volume: 22(3) Issue: 3 Pages: 28-28
- DOI
  10.1007/s11912-020-0888-x
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17H04340, KAKENHI-PROJECT-16H06277, KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-20H03828
[Journal Article] Perioperative treatments for stage IB-IIB uterine cervical cancer2020
- Author(s)
  Shimada Muneaki、Tokunaga Hideki、Kobayashi Hiroaki、Ishikawa Mitsuya、Yaegashi Nobuo
- Journal Title
  
  Japanese Journal of Clinical Oncology
  
  Volume: 50 Issue: 2 Pages: 99-103
- DOI
  10.1093/jjco/hyz200
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K11265
[Journal Article] Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study2019
- Author(s)
  Matsuo Koji、Shimada Muneaki、Matsuzaki Shinya、Machida Hiroko、Nagase Yoshikazu、Saito Toshiaki、Kamiura Shoji、Iwata Takashi、Sugiyama Toru、Mikami Mikio
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 8 Issue: 11 Pages: 1822-1822
- DOI
  10.3390/jcm8111822
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-17H04340, KAKENHI-PROJECT-16H06277
[Journal Article] Neoadjuvant chemotherapy with taxane and platinum followed by radical hysterectomy for stage IB2-IIB cervical cancer: Impact of histology type on survival.2019
- Author(s)
  Matsuo K, Shimada M, Yamaguchi S, Kigawa J, Tokunaga H, Tabata T, Kodama J, Kawana K, Mikami M, Sugiyama T.
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 30: 8(2) Issue: 2 Pages: 156-169
- DOI
  10.3390/jcm8020156
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-18K09303, KAKENHI-PROJECT-17H04340
[Journal Article] Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer2019
- Author(s)
  Matsuo Koji、Shimada Muneaki、Yamaguchi Satoshi、Matoda Maki、Nakanishi Toru、Kikkawa Fumitaka、Ohmichi Masahide、Okamoto Aikou、Sugiyama Toru、Mikami Mikio
- Journal Title
  
  Obstetrics & Gynecology
  
  Volume: 133 Issue: 6 Pages: 1086-1098
- DOI
  10.1097/aog.0000000000003280
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-17H04340, KAKENHI-PROJECT-16H06277
[Journal Article] Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.2019
- Author(s)
  Matsuo K, Shimada M, Nakamura K, Takei Y, Ushijima K, Sumi T, Ohara T, Yahata H, Mikami M, Sugiyama T.
- Journal Title
  
  Eur J Sur Oncol
  
  Volume: - Issue: 8 Pages: 1417-1424
- DOI
  10.1016/j.ejso.2019.02.019
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-17H04340, KAKENHI-PROJECT-16H06277
[Journal Article] Chemoresistance of gastric-type mucinous carcinoma of the uterine cervix: a study of the Sankai Gynecology Study Group.2018
- Author(s)
  Kojima A, Shimada M, Mikami Y, Nagao S, Takeshima N, Sugiyama T, Teramoto N, Kiyokawa T, Kigawa J, Nishimura R, Sankai Gynecology Study Group (SGSG)
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 28(1) Issue: 1 Pages: 99-106
- DOI
  10.1097/igc.0000000000001145
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K11265
[Journal Article] Risk stratification models for peri-aortic lymph node metastasis and recurrence in stage IB-IIB cervical cancer.2018
- Author(s)
  Matsuo K, Shimada M, Tsuyoshi Saito T, Takehara K, Tokunaga H, Watanabe Y, Todo Y, Morishige K, Mikami M, Sugiyama T.
- Journal Title
  
  J Gynecol Oncol.
  
  Volume: 29 (1):e11. Issue: 1
- DOI
  10.3802/jgo.2018.29.e11
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-18K09257, KAKENHI-PROJECT-17H04340
[Journal Article] Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer2017
- Author(s)
  Matsuo Koji、Shimada Muneaki、Yokota Harushige、Satoh Toyomi、Katabuchi Hidetaka、Kodama Shoji、Sasaki Hiroshi、Matsumura Noriomi、Mikami Mikio、Sugiyama Toru
- Journal Title
  
  Oncotarget
  
  Volume: 8 Issue: 63 Pages: 106866-106875
- DOI
  10.18632/oncotarget.22437
- NAID
  120007134533
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-17H04340, KAKENHI-PROJECT-16K15707
[Journal Article] Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.2017
- Author(s)
  Matsuo K, Shimada M, Aoki Y, Sakamoto M, Takeshima N, Fujiwara H, Matsumoto T, Mikami M, Sugiyama T.
- Journal Title
  
  Int J Cancer
  
  Volume: 141 (5) Issue: 5 Pages: 1042-1051
- DOI
  10.1002/ijc.30793
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K11265, KAKENHI-PROJECT-17H04340
[Journal Article] The PI3K/mTOR dual Inhibitor NVP-BEZ235 Reduces Growth of Ovarian Clear Cell Carcinoma.2014
- Author(s)
  Oishi T, Itamochi H, Kudoh A, Nonaka M, Kato M, Nishimura M, Oumi N, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Oncology Report
  
  Volume: 32
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25462594
[Journal Article] Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.2014
- Author(s)
  Itamochi H, Nishimura M, Oumi N, Kato M, Oishi T, Shimada M, Sato S, Naniwa J, Sato S, Kudoh A, Kigawa J, Harada H.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 1 Pages: 61-69
- DOI
  10.1097/igc.0000000000000014
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Dual inhibition of phosphatidylinositol 3’-kinase and mammalian target of rapamycin using NVP-BEZ235 as a vovel therapeutic approach for mucinous adenocarcinoma of the ovary.2014
- Author(s)
  Kudoh A, Oishi T, Itamochi H, Sato S, Naniwa J, Sato S, Shimada M, Kigawa J, Harada T.
- Journal Title
  
  Int J Gynecol Cancer
  
  Volume: 24 Issue: 3 Pages: 444-453
- DOI
  10.1097/igc.0000000000000091
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA gene.2013
- Author(s)
  Itamochi H., Kato M., Nishimura M., Oumi N., Oishi T., Shimada M., Sato S., Naniwa J., Sato S., Nonaka M., Kudoh A., Terakawa N., Kigawa J., and Harada T.
- Journal Title
  
  Human Cell
  
  Volume: 26 Issue: 3 Pages: 121-127
- DOI
  10.1007/s13577-013-0062-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24592517
[Journal Article] Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging2005
- Author(s)
  Muneaki, Shimada
- Journal Title
  
  International Journal of Gynecological Cancer 15
  
  Pages: 601-605
- Description
  「研究成果報告書概要(欧文)」より
- Data Source
  KAKENHI-PROJECT-17591737
[Journal Article] Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging.2005
- Author(s)
  Muneaki Shimada
- Journal Title
  
  International Journal of Gynecological Cancer 15
  
  Pages: 601-605
- Description
  「研究成果報告書概要(和文)」より
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17591737
[Presentation] How to treat Non-high grade serous carcinoma - Low-grade serous carcinoma, Clear cell carcinoma, Mucinous carcinoma-2023
- Author(s)
  Muneaki Shimada
- Organizer
  International Gynecologic Cancer Society 2023, Master Session, Seoul
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K09486
[Presentation] 子宮体癌における血漿メタボローム解析による新規バイオマーカーの探索2023
- Author(s)
  萩原達也，島田宗昭, 菱沼英史, 李　賓, 橋本栄文, 栃木実佳子, 遠藤　俊, 清水孝規, 湊　純子, 渋谷祐介, 橋本千明, 石橋ますみ, 重田昌吾, 徳永英樹, 八重樫伸生
- Organizer
  第65回日本婦人科腫瘍学会　高得点演題
- Data Source
  KAKENHI-PROJECT-21K09486
[Presentation] 当院における遺伝性乳癌卵巣癌症候群に対するリスク低減卵管卵巣摘出術の経験2022
- Author(s)
  湊純子，島田宗昭, 萩原達也, 橋本栄文, 湊敬道, 橋本千明, 石橋ますみ, 重田昌吾, 永井智之, 徳永英樹, 八重樫伸生
- Organizer
  第74回日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-21K09531
[Presentation] リスク低減卵管卵巣摘出術待機中にIIIA1(ii)期の卵管癌を発症した遺伝性乳癌卵巣癌症候群の一例2022
- Author(s)
  村川真理弥，湊純子, 熊谷奈津美, 萩原達也, 橋本栄文, 高橋友梨, 栃木実佳子, 橋本千明, 石橋ますみ, 重田昌吾, 永井智之, 徳永英樹, 島田宗昭, 八重樫伸生
- Organizer
  第151回東北連合産科婦人科学会総会
- Data Source
  KAKENHI-PROJECT-21K09531
[Presentation] チロシンキナーゼ受容体型蛋白TIE-1の卵巣癌に対する抗腫瘍効果の検討2022
- Author(s)
  石橋ますみ，徳永英樹, 重田昌吾, 永井智之, 島田宗昭, 八重樫伸生
- Organizer
  第64回日本婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-21K09531
[Presentation] 進行卵巣癌における初回化学療法後の維持療法選択に関する後方視的検討2022
- Author(s)
  橋本栄文，萩原達也, 遠藤俊, 清水孝規, 湊敬道, 湊純子, 橋本千明, 石橋ますみ, 重田昌吾, 徳永英樹, 島田宗昭, 八重樫伸生
- Organizer
  第74回日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-21K09531
[Presentation] 卵巣癌既発症のBRCA病的バリアント保持者に対する乳房サーベイランスの現状2022
- Author(s)
  湊純子，島田宗昭, 橋本栄文, 萩原達也, 湊敬道, 橋本千明, 石橋ますみ, 重田昌吾, 永井智之, 徳永英樹, 八重樫伸生
- Organizer
  第64回日本婦人科腫瘍学会
- Data Source
  KAKENHI-PROJECT-21K09531
[Presentation] Functional analysis of ZFHX4 as a novel therapeutic target in ovarian cancer2020
- Author(s)
  Yoshiko Oyama, Shigeta Shogo, Keita Tsuji, Muneaki Shimada, Nobuo Yaegashi
- Organizer
  American Association for cancer research Annual Meeting 2020
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09747
[Presentation] 卵巣明細胞腺癌におけるphosphatidylinositide 3-kinase (PI3K) - Akt経路およびARID1A蛋白発現と臨床的意義の検討2015
- Author(s)
  大石徹郎、板持広明、近江奈央、庄子忠宏、嵯峨泰、藤原寛行、島田宗昭、杉山徹、鈴木光明、紀川純三、原田省
- Organizer
  第67回日本産科婦人科学会学術講演会
- Place of Presentation
  神奈川県横浜市
- Year and Date
  2015-04-09
- Data Source
  KAKENHI-PROJECT-25462594
[Presentation] 卵巣明細胞腺癌におけるPI3K-Akt 経路およびARID1A 蛋白発現と臨床的意義の検討2015
- Author(s)
  大石徹郎、板持広明、庄子忠宏、嵯峨泰、藤原寛行、島田宗昭、杉山徹、鈴木光明、紀川純三、原田省
- Organizer
  第74回日本癌学会
- Place of Presentation
  愛知県名古屋市
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25462594
[Presentation] Fibroblast growth factor receptor 2 is associated with poor overall survival in clear cell carcinoma of the ovary and may be a novel therapeutic approach.2015
- Author(s)
  Itamochi H, Oumi N, Oishi T, Taniguchi F, Shoji T, Saga Y, Fujiwara H, Shimada M, Sugiyama T, Suzuki M, Kigawa J, Harada T.
- Organizer
  106th Annual Meeting of the American Association for Cancer Research
- Place of Presentation
  フィラデルフィア（アメリカ合衆国）
- Year and Date
  2015-04-21
- Data Source
  KAKENHI-PROJECT-24592517
[]

1. TOKUNAGA Hideki (30595559)

# of Collaborated Projects: 6 results

# of Collaborated Products: 21 results
2. 重田昌吾 (90842633)

# of Collaborated Projects: 4 results

# of Collaborated Products: 10 results
3. SATO Syinya (10423261)

# of Collaborated Projects: 3 results

# of Collaborated Products: 4 results
4. ITAMOCHI Hiroaki (20314601)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
5. OISHI Tetsuro (80359877)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
6. KIGAWA Junzo (00177784)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
7. SATO Seiya (30621007)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
8. HARADA Tasuku (40218649)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
9. CHIKUMI Jun (70467702)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
10. TARAKAWA Naoki (90163906)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. TSUJI Keita (10835341)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
12. YAEGASHI Nobuo (00241597)

# of Collaborated Projects: 1 results

# of Collaborated Products: 7 results
13. 金森康展 (70283984)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 高橋正国 (30379622)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 北谷和之 (40539235)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 永井智之 (00704298)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. 安田純 (00281684)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
18. 石橋ますみ (20821383)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
19. 平沢晃 (90296658)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
20. 岡本愛光 (20204026)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
21. 菱沼英史 (10824609)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
22. NANIWA Jun

# of Collaborated Projects: 0 results

# of Collaborated Products: 4 results
23. YOSHIHARA Kousuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. BABA Tsukasa

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
25. 三上幹男

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
26. 荻島創一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Shimada Muneaki 島田 宗昭

SHIMADA Muneaki 島田 宗昭

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a New Treatment Strategy for Refractory Ovarian Mucinous CarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

An attempt to establish a new treatment for non-squamous cell carcinoma of the uterine cervixPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial Ovarian Carcinomas2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of predictive biomarkers for diagnosis and radiation sensitivity of uterine cervical cancer using wide‐targeted metabolomics2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Homologous Recombination Inquiry Through Ovarian Malignancy Investigations: JGOG3025 study.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] An Attempt to Develop a New Treatment Strategy for Rare Refractory Gynecological Malignancies: The Japanese Gynecologic Oncology Group2023

Author(s)

Journal Title

Shimada Muneaki 島田宗昭

SHIMADA Muneaki 島田宗昭